Monday, August 14, 2017 1:27:17 PM
OTC Disclosure & News Service
View:ActiveInactive
Publish Date
Report Title
Period End Date
Status
Apr 17, 2016 Quarterly Report Mar 31, 2016 Active
Apr 17, 2016 Attorney Letter with Respect to Current Information Dec 31, 2015 Active
Apr 12, 2016 Annual Report - Corrected Dec 31, 2015 Active
Apr 6, 2016 Annual Report Dec 31, 2015 Active
Mar 8, 2016 Quarterly Report - AMENDED Sept 30, 2015 Active
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM